New Valve Medical Successfully Holds 2025 Annual Celebration Themed 'Setting Sail with Heart, Powering a New Journey'

Looking Back on the Path of Dedication, Sailing Together in the Sea of Hearts

Gather Role Model Strength, Showcase Team Spirit

Draw a New Blueprint Together, Embark on a New Journey Anew

My connection with NewMed dates back to 2016, making me one of the earliest investors in the company. Over the past nine years, NewMed has faced countless challenges and storms, yet it has not only survived adversity but thrived with remarkable resilience and adaptability. What particularly surprised me was the approval and launch of the Prizvalve product last year. Within just three months, NewMed not only achieved what seemed like an impossible sales target but also gained widespread market recognition and acclaim.

Here, I would like to emphasize that it is precisely based on such a solid foundation and the courage to continuously break through that I have unprecedented confidence in the future of our company. Today, I hope to convey this unwavering confidence to everyone present, so let us jointly look forward to and participate in a more brilliant tomorrow for NewMed.

I am the leader of NewMed's Prizvalve Transcatheter Aortic Valve System, and I have been involved in this project since 2020. Under the guidance of Mr. Yu, we successfully completed the first domestically developed balloon-expandable valve to be marketed in China. Looking back at the past year, especially when we faced the seemingly impossible task of obtaining product approval in the third quarter, the anxiety and pressure we felt are still unforgettable.

Miracles often arrive quietly when least expected. After countless days and nights of relentless efforts, numerous adjustments, and optimizations to our plans, we achieved our goal ahead of schedule—on the inspiring day of August 14th, our product was successfully launched! This accomplishment is not only a recognition of our product's quality but also the highest praise for our team's intelligence, courage, and perseverance.

2024 is a crucial year for our company as we officially step into commercialization. In fact, even before Prizvalve obtained its registration certificate, we had already embarked on laying the groundwork for commercialization. It was a period full of challenges and exploration, during which we delved deep into the market, gained insights into demands, built channels, and paved a solid path for the product's market entry.

Finally, in the last four months of 2024, our efforts, like seeds waiting silently for blossoms, have welcomed a brilliant bloom. The enthusiastic market response and widespread customer recognition are the best proof of our earlier strategic planning and hard work. Our Marketing Center will continue to cultivate the market, optimize services, and enhance brand influence, ensuring that every product achieves precise reach to target customers and maximizes commercial value.

NewMed was the starting point of my career after graduation, and HuanSong was the first major challenge that I followed from start to finish. President Yu often tells us: "In medical projects, patience is key—it’s a long journey that takes 8 to 9 years." So far, I’ve been on this journey for four and a half years. Along the way, I haven’t been fighting alone. The company’s leadership and colleagues have always been with me—they are not only my partners at work but also my pillars of strength.

The recognition from clinical feedback is the greatest affirmation of our work. Every time I hear a doctor say, "With this product, I feel confident to perform this surgery," and every time I see patients regain their health because of our product, my heart fills with immense pride and satisfaction. These moments make me even more convinced that every effort we make is valuable and meaningful.

I have witnessed the entire process of the company from its inception to growth, and now to steady progress. Every breakthrough and every leap forward is inseparable from the joint efforts and selfless dedication of every member of the team. You are the most valuable asset of the company, and the core force driving us forward.

The medical device industry is a great undertaking related to human health and well-being. It requires us not only to possess cutting-edge technological innovation capabilities but also to have a deep concern for life safety and a strong sense of social responsibility. Based on this philosophy, NewMed has continuously focused on original research and innovation, developing several cutting-edge products, and has achieved remarkable results in technology development, market expansion, customer service, and other fields.

First and foremost, I would like to express my heartfelt gratitude to all NewMed employees for their hard work over the past year, which has enabled NewMed Medical to rise against the odds. The development of NewMed is built upon the collective efforts of every single NewMed employee. The goals and tasks that NewMed employees have been striving for have always been challenging, but instead of retreating in the face of difficulties, all NewMed employees have become even more united. With sweat and wisdom, they have been working tirelessly to propel the massive ship that is NewMed forward through turbulent waters, making it more resilient and full of hope amidst the storms.

NewMed is about to reach a pivotal turning point for new development, stepping into the more challenging arena of high-end medical devices. Looking ahead at the road before us, and in the face of entirely new opportunities and challenges, we need to embrace a broad perspective, think innovatively, and pursue change with determination. We must drive transformation with unwavering will, accept it with an open mindset, and lead it with creative thinking. Following this new direction, we will continue to passionately strive forward, overcoming obstacles and constantly building up the powerful momentum that propels us, the NewMed team, ever onward.